Literature DB >> 15987092

From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry.

Anne E Boyer1, Hercules Moura, Adrian R Woolfitt, Suzanne R Kalb, Lisa G McWilliams, Antonis Pavlopoulos, Jurgen G Schmidt, David L Ashley, John R Barr.   

Abstract

We have developed an assay (Endopep-MS) that detects the specific endoproteinase activities of all seven BoNT types by mass spectrometry (MS). Each BoNT type cleaves a unique site on proteins involved in neuronal transmission. Target peptide substrates based on these proteins identify a BoNT type by its enzymatic action on the substrate and the production of two peptide products, which are then detected by matrix-assisted laser desorption/ionization time-of-flight MS or liquid chromatography electrospray ionization MS/MS. We showed the ability to detect all seven toxin types in a multiplexed assay format. The detection limits achieved range from 0.039 to 0.625 mouse LD(50)/mL for toxin types A, B, E, and F in a buffer system. The Endopep-MS assay is the first to differentiate all seven BoNT types, is sensitive, specific, and has the potential to quantify toxin activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987092     DOI: 10.1021/ac050485f

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  49 in total

1.  Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.

Authors:  Suzanne R Kalb; John R Barr
Journal:  Rev Anal Chem       Date:  2013-08       Impact factor: 3.067

2.  Outbreak of botulism type A in dairy cows detected by MALDI-TOF mass spectrometry.

Authors:  Elisha A Frye; Christina Egan; Michael J Perry; Esther E Crouch; Kyle E Burbank; Kathleen M Kelly
Journal:  J Vet Diagn Invest       Date:  2020-07-25       Impact factor: 1.279

3.  Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.

Authors:  Dongxia Wang; Jakub Baudys; Yiming Ye; Jon C Rees; John R Barr; James L Pirkle; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2012-09-24       Impact factor: 3.365

4.  Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.

Authors:  Karine Bagramyan; Bruce E Kaplan; Luisa W Cheng; Jasmin Strotmeier; Andreas Rummel; Markus Kalkum
Journal:  Anal Chem       Date:  2013-05-22       Impact factor: 6.986

5.  In vitro detection and quantification of botulinum neurotoxin type e activity in avian blood.

Authors:  Timothy M Piazza; David S Blehert; F Mark Dunning; Brenda M Berlowski-Zier; Füsûn N Zeytin; Michael D Samuel; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2011-09-09       Impact factor: 4.792

6.  Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Authors:  F Mark Dunning; Daniel R Ruge; Timothy M Piazza; Larry H Stanker; Füsûn N Zeytin; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

7.  Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A Botulism in France.

Authors:  Christelle Mazuet; Eric Ezan; Hervé Volland; Michel Robert Popoff; François Becher
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

8.  Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates.

Authors:  Dongxia Wang; Joan Krilich; Jakub Baudys; John R Barr; Suzanne R Kalb
Journal:  Bioorg Med Chem       Date:  2015-04-10       Impact factor: 3.641

9.  Coupling immunomagnetic separation on magnetic beads with matrix-assisted laser desorption ionization-time of flight mass spectrometry for detection of staphylococcal enterotoxin B.

Authors:  Gitta Schlosser; Petr Kacer; Marek Kuzma; Zoltán Szilágyi; Alida Sorrentino; Carla Manzo; Rosa Pizzano; Livia Malorni; Gabriella Pocsfalvi
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

10.  Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.

Authors:  Saedeh Dadgar; Zack Ramjan; Wely B Floriano
Journal:  J Med Chem       Date:  2013-03-29       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.